{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:39:01Z","timestamp":1780677541206,"version":"3.54.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Nurs"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cancer treatment\u2013induced bone loss is an important long-term effect among breast cancer survivors. Little is known, however, about the pattern of bone loss and the factors associated with it.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>The aim of this study was to examine annual bone health changes and factors associated with bone loss for 3 years after diagnosis among women with breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ninety-nine newly diagnosed women with breast cancer (mean age, 51.1 years) were enrolled in a prospective longitudinal study. Bone mineral density (BMD) was measured with dual-energy x-ray absorptiometry at baseline and yearly for 3 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During the 3-year follow-up, the proportion of women who had osteopenia or osteoporosis increased from 33.3% to 62.5%. The BMD of the participants significantly decreased 6.8% in the lumbar spine, 4.6% in the femur neck, and 3.5% in the total hip, with bone loss the greatest in the first year. In multiple linear regression analysis, chemotherapy was significantly associated with bone loss at all sites, and premenopausal status at diagnosis was significantly related to bone loss at the lumbar spine. We found no significant relationship between health behavior status and BMD change at any site.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Women newly diagnosed with breast cancer can lose up to 6.8% of BMD during a 3-year follow-up. Chemotherapy and premenopausal status are important risk factors for bone loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Implications for Practice<\/jats:title>\n            <jats:p>Identification of premenopausal women at diagnosis and monitoring BMD before and after chemotherapy are key for promoting bone health in women with breast cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ncc.0000000000000586","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T20:23:09Z","timestamp":1522182189000},"page":"164-172","source":"Crossref","is-referenced-by-count":10,"title":["Changes in Bone Mineral Density in Women With Breast Cancer"],"prefix":"10.1097","volume":"42","author":[{"given":"Soo Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Up","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Sook","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"bib1-20230920","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"bib2-20230920","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4143\/crt.2017.118","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014","volume":"49","year":"2017","journal-title":"Cancer Res Treat"},{"issue":"1","key":"bib3-20230920","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/annonc\/mdl333","article-title":"Health-related quality of life in disease-free survivors of breast cancer with the general population","volume":"18","year":"2007","journal-title":"Ann Oncol"},{"issue":"30","key":"bib4-20230920","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2012.42.2097","article-title":"Bone health in adult cancer survivorship","volume":"30","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8 suppl","key":"bib5-20230920","first-page":"2288","article-title":"A prospective model of care for breast cancer rehabilitation: bone health and arthralgias","volume":"118","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"bib6-20230920","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjc.1990.58","article-title":"Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer","volume":"61","year":"1990","journal-title":"Br J Cancer"},{"issue":"1","key":"bib7-20230920","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.1999.17.1.120","article-title":"Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"issue":"14","key":"bib8-20230920","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"bib9-20230920","first-page":"183","article-title":"NCCN guideline update: breast cancer version 1.2004","volume":"2","year":"2004","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"bib10-20230920","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","article-title":"Osteoporosis due to cancer treatment: pathogenesis and management","volume":"18","year":"2000","journal-title":"J Clin Oncol"},{"issue":"6","key":"bib11-20230920","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer","volume":"30","year":"2003","journal-title":"Semin Oncol"},{"issue":"1","key":"bib12-20230920","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"bib13-20230920","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10549-010-0899-7","article-title":"Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?","volume":"123","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"bib14-20230920","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/bjc.1997.105","article-title":"Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens","volume":"75","year":"1997","journal-title":"Br J Cancer"},{"issue":"9","key":"bib15-20230920","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (arimidex, tamoxifen alone or in combination) trial efficacy and safety update analyses","volume":"98","year":"2003","journal-title":"Cancer"},{"issue":"7","key":"bib16-20230920","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9453","key":"bib17-20230920","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"7\u20138","key":"bib18-20230920","first-page":"1179","article-title":"A high incidence of vertebral fracture in women with breast cancer","volume":"79","year":"1999","journal-title":"Br J Cancer"},{"issue":"5","key":"bib19-20230920","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","article-title":"Fracture risk among breast cancer survivors: results from the women's health initiative observational study","volume":"165","year":"2005","journal-title":"Arch Intern Med"},{"issue":"11","key":"bib20-20230920","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00198-010-1493-x","article-title":"Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients","volume":"22","year":"2011","journal-title":"Osteoporos Int"},{"issue":"3","key":"bib21-20230920","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3322\/caac.20103","article-title":"Aging and osteoporosis in breast and prostate cancer","volume":"61","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"bib22-20230920","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejca.2010.11.024","article-title":"Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809","volume":"47","year":"2011","journal-title":"Eur J Cancer"},{"issue":"18","key":"bib23-20230920","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","article-title":"The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer","volume":"45","year":"2009","journal-title":"Eur J Cancer"},{"issue":"10","key":"bib24-20230920","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1007\/s00520-016-3250-y","article-title":"Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer","volume":"24","year":"2016","journal-title":"Support Care Cancer"},{"issue":"5","key":"bib25-20230920","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cncr.23259","article-title":"Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST study results","volume":"112","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"bib26-20230920","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clbc.2011.08.002","article-title":"Immediate administration of zoledronic acid reduces aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer: 12-month analysis of the E-ZO-FAST trial","volume":"12","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"bib27-20230920","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/02841860410032885","article-title":"Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients","volume":"43","year":"2004","journal-title":"Acta Oncol"},{"issue":"12","key":"bib28-20230920","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00198-003-1508-y","article-title":"Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)","volume":"14","year":"2003","journal-title":"Osteoporos Int"},{"issue":"5","key":"bib29-20230920","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3322\/canjclin.56.5.254","article-title":"American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity","volume":"56","year":"2006","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"bib30-20230920","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00198-006-0109-y","article-title":"Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women","volume":"17","year":"2006","journal-title":"Osteoporos Int"},{"issue":"6","key":"bib31-20230920","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1751-1097.2006.tb09833.x","article-title":"Calculated ultraviolet exposure levels for a healthy vitamin D status","volume":"82","year":"2006","journal-title":"Photochem Photobiol"},{"issue":"6","key":"bib32-20230920","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1053\/j.seminoncol.2006.08.011","article-title":"Toxicity of aromatase inhibitors","volume":"33","year":"2006","journal-title":"Semin Oncol"},{"issue":"5","key":"bib33-20230920","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00198-012-2143-2","article-title":"Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial","volume":"24","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"bib34-20230920","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.apmr.2014.08.010","article-title":"Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial","volume":"96","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"bib35-20230920","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11764-010-0122-1","article-title":"A review of exercise interventions to improve bone health in adult cancer survivors","volume":"4","year":"2010","journal-title":"J Cancer Surviv"},{"issue":"10","key":"bib36-20230920","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00198-013-2343-4","article-title":"Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D","volume":"24","year":"2013","journal-title":"Osteoporos Int"},{"issue":"12","key":"bib37-20230920","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"bib38-20230920","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","article-title":"Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression","volume":"175","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"bib39-20230920","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2007.03.026","article-title":"Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy","volume":"70","year":"2007","journal-title":"Urology"},{"issue":"6","key":"bib40-20230920","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an endocrine society clinical practice guideline","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"bib41-20230920","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.1780370208","article-title":"The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats","volume":"37","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"2","key":"bib42-20230920","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000146262","article-title":"Study of histomorphometric changes of the mandibular condyles in neonatal and juvenile rats after administration of cyclophosphamide","volume":"127","year":"1986","journal-title":"Acta Anatomica (Basel)"},{"issue":"2","key":"bib43-20230920","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6603258","article-title":"Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids","volume":"95","year":"2006","journal-title":"Br J Cancer"},{"key":"bib44-20230920","first-page":"384-2407-11-384","article-title":"Increased fracture rate in women with breast cancer: a review of the hidden risk","volume":"11","year":"2011","journal-title":"BMC Cancer"},{"issue":"4","key":"bib45-20230920","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11914-013-0179-7","article-title":"Skeletal manifestations of treatment of breast cancer","volume":"11","year":"2013","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"bib46-20230920","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0360-3016(92)90895-O","article-title":"Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer","volume":"23","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"bib47-20230920","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00198-007-0501-2","article-title":"Calcium and vitamin D intake influence bone mass, but not short-term fracture risk, in Caucasian postmenopausal women from the national osteoporosis risk assessment (NORA) study","volume":"19","year":"2008","journal-title":"Osteoporos Int"},{"issue":"3","key":"bib48-20230920","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.critrevonc.2013.07.002","article-title":"Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy","volume":"88","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"bib49-20230920","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejon.2012.07.003","article-title":"Low bone density in breast cancer survivors in Korea: prevalence, risk factors and associations with health-related quality of life","volume":"17","year":"2013","journal-title":"Eur J Oncol Nurs"},{"issue":"10","key":"bib50-20230920","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1745-7599.2006.00165.x","article-title":"Health behaviors in breast cancer survivors experiencing bone loss","volume":"18","year":"2006","journal-title":"J Am Acad Nurse Pract"},{"issue":"10","key":"bib51-20230920","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00268-010-0683-1","article-title":"Is breast cancer the same disease in Asian and Western countries","volume":"34","year":"2010","journal-title":"World J Surg"}],"container-title":["Cancer Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002820-201903000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T18:04:19Z","timestamp":1695233059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002820-201903000-00009"}},"subtitle":["A Prospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ncc.0000000000000586","relation":{},"ISSN":["1538-9804","0162-220X"],"issn-type":[{"value":"1538-9804","type":"electronic"},{"value":"0162-220X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}